Sorrento Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sorrento Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19% to $62,839,000. Profit margin reached -890%. Total operating expenses were $407,888,000.
Profit Margin
| 2013 | 460K | -21.91M | -4763.26% |
|---|---|---|---|
| 2014 | 3.82M | -34.65M | -906.07% |
| 2015 | 4.59M | -45.81M | -998.06% |
| 2016 | 8.15M | -60.92M | -747.34% |
| 2017 | 151.85M | 9.06M | 5.97% |
| 2018 | 21.19M | -203.54M | -960.41% |
| 2019 | 31.43M | -359.10M | -1142.48% |
| 2020 | 39.98M | -308.56M | -771.69% |
| 2021 | 52.90M | -429.01M | -810.93% |
| 2022 | 62.83M | -559.33M | -890.1% |
0L85.L Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 62.83M | 52.90M | 39.98M | 31.43M | 21.19M | 151.85M | 8.15M | 4.59M | 3.82M | 460K |
Cost of revenue | 33.45M | 13.03M | 9.94M | 12.23M | 7.06M | 11.02M | 811K | 1.95M | 2.04M | 9.02M |
Gross profit | 29.38M | 39.87M | 30.04M | 19.19M | 14.13M | 140.83M | 7.34M | 2.64M | 1.78M | -8.56M |
Operating exp. | ||||||||||
Research and development | 221.22M | 206.92M | 111.34M | 106.87M | 76.96M | 55.53M | 42.17M | 31.34M | 23.98M | 15.00M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | -5.37M | 0 | 0 | 0 | 0 |
Total operating expenses | 407.88M | 407.91M | 231.57M | 214.37M | 143.61M | 88.49M | 67.23M | 52.63M | 36.31M | 13.10M |
Operating income | -378.50M | -368.04M | -201.52M | -195.18M | -150.42M | 52.33M | -96.77M | -74.00M | -34.74M | -15.68M |
Other income (expenses), net | -183.24M | -94.48M | -66.06M | -164.39M | -63.35M | -10.02M | 31.94M | 36.23M | -1.61M | -6.22M |
Income before tax | -561.74M | -462.52M | -310.58M | -359.57M | -213.78M | 15.31M | -64.83M | -13.76M | -36.35M | -21.91M |
Income tax expense | -2.41M | -33.51M | -2.01M | -473K | -6.27M | -36.03M | -896K | 36.31M | -1.70M | 0 |
Net income | -559.33M | -429.01M | -308.56M | -359.10M | -203.54M | 9.06M | -60.92M | -45.81M | -34.65M | -21.91M |
Earnings per share | ||||||||||
Basic EPS | -1.33 | -1.46 | -1.34 | -2.56 | -1.92 | 0.13 | -1.21 | -1.24 | -1.3 | -1.46 |
Diluted EPS | -1.33 | -1.46 | -1.34 | -2.56 | -1.92 | 0.13 | -1.21 | -1.24 | -1.3 | -1.46 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |